MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Global In Vitro Diagnostics Market to Grow To $69.1 billion by 2017

The global in vitro diagnostics market is expected to grow to $69.1 billion by 2017, up from $49.2 billion in 2012, driven in large part by a growing trend of self-testing.  

The global in vitro diagnostics (IVD) market is expected to grow to $69.1 billion by 2017, up from $49.2 billion in 2012, according to a new report by Research and Markets.

The growth represents a 7% compounded annual growth rate in five years.

Self-testing is the biggest trend fueling the growth of the industry whereas before patients used to visit hospitals for certain kinds of diagnosis. As a result, the number of point-of-care testing products has grown.

Other factors that are contributing to the growth of the IVD industry globally are “ongoing developments in analytical laboratory automation, swift progress in various fields of diagnosis such as … molecular diagnosis, immunoassays, hematology, flow cytometry, microbiology and finally, the geographical market expansion within emerging countries.”

While the U.S., followed by Europe will continue to account for the largest markets for the industry, emerging regions like the BRIC countries represent areas of the fastest growth.

The industry can be categorized into the following segments based on technology:

  • Clinical chemistry
  • Immunochemistry
  • Molecular diagnostics
  • Hematology
  • Coagulation
  • Microbiology
  • Others

The IVD industry can also be broken down into the following sub categories based on applications:

  • Diabetes
  • Infectious diseases
  • Oncology
  • Cardiology
  • Nephrology
  • Auto-immune diseases
  • AIDS
  • Drug testing
  • Others

Some of the leading companies in the space are Abbott Laboratories, Roche Diagnostics, Becton Dickinson & Co., Siemens Healthcare of Germany and Diagnostica Stago SAS of France.

-- By Arundhati Parmar, Senior Editor, MD+DI
[email protected]

Learn more about the IVD business landscape in the future by registering for the IVD Business Strategy Conference to be held in San Diego, Nov.6-8.
Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.